- Brand: NovosevenGeneric: Coagulation Factor VIIa (Recombinant)
- Brand: SevenfactGeneric: Coagulation factor VIIa (recombinant)-jncw for Injection
- Brand: MononineGeneric: Coagulation Factor IX (Human)
- Brand: BioclateGeneric: Antihemophilic Factor
- Brand: KonyneGeneric: Factor IX Complex
- Brand: RefactoGeneric: Antihemophilic Factor
- Brand: Proplex-TGeneric: Factor IX Complex
- Brand: KoateGeneric: Antihemophilic Factor
- Brand: Autoplex-TGeneric: Anti-Inhibitor Coagulant Complex, Heat Treated
- Brand: KcentraGeneric: Prothrombin Complex Concentrate (Human)
- Brand: B12Generic: Liver-Stomach Concentrate With Intrinsic Factor
- Brand: RecombinateGeneric: Antihemophilic Factor (Recombinant)
- Brand: XynthaGeneric: Antihemophilic Factor
- Brand: RixubisGeneric: Coagulation Factor IX (Recombinant) for Intramuscular Injection
- Brand: BeneFIXGeneric: Coagulation Factor IX Recombinant for Injection
- Brand: VonvendiGeneric: von Willebrand factor (Recombinant) for Injection
- Brand: Monoclate-PGeneric: Antihemophilic Factor
- Brand: IdelvionGeneric: Coagulation Factor IX (Recombinant) Albumin Fusion Protein Lyophilized Powder Intravenous Injection
- Brand: AdvateGeneric: [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method] for Intravenous Injection
- Brand: Helixate FSGeneric: Antihemophilic Factor (Recombinant)
- Brand: AdynovateGeneric: Antihemophilic Factor (Recombinant), PEGylated for Injection
- Brand: JiviGeneric: Antihemophilic Factor (Recombinant), PEGylated-aucl for Injection
- Brand: AfstylaGeneric: Antihemophilic Factor Recombinant Intravenous Injection
- Brand: KovaltryGeneric: Antihemophilic Factor (Recombinant) for Intravenous Administration
- Brand: Kogenate FSGeneric: Antihemophilic Factor (Recombinant)
- Brand: CoagadexGeneric: Coagulation Factor X Lyophilized Powder
- Brand: IxinityGeneric: [Coagulation Factor IX (Recombinant)] for Injection
- Brand: Bebulin VHGeneric: Factor IX Complex Intravenous Administration
- Brand: NuwiqGeneric: Antihemophilic Factor Recombinant Intravenous Infusion
- Brand: AlprolixGeneric: [Coagulation Factor IX (Recombinant), Fc Fusion Protein], Lyophilized Powder for Solution For Intravenous Injection
- Brand: EloctateGeneric: Antihemophilic Factor (Recombinant), Fc Fusion Protein for Intravenous Infusion
- Brand: Heparin Preservative FreeGeneric: Heparin Sodium Injection Preservative Free
- Brand: RebinynGeneric: Coagulation Factor IX (Recombinant)
- Brand: LovenoxGeneric: Enoxaparin Sodium Injection
- Brand: VibativGeneric: Telavancin for Injection
- Brand: ProfilnineGeneric: Factor IX Complex Intravenous Administration
- Brand: CrofabGeneric: Crotalidae Polyvalent Immune Fab Ovine
- Brand: DDAVP InjectionGeneric: Desmopressin Acetate Injection
- Brand: StimateGeneric: Desmopressin Acetate Nasal Spray
- Brand: NovoeightGeneric: Antihemophilic Factor (Recombinant) Lyophilized Powder for Intravenous Injection
- Brand: HextendGeneric: 6% Hetastarch in Lactated Electrolyte Injection
- Brand: WilateGeneric: von Willebrand Factor/Coagulation Factor VIII Complex (Human)
- Brand: Generic:
- Brand: RifadinGeneric: Rifampin
- Brand: HemlibraGeneric: Emicizumab-Kxwh Injection, for Subcutaneous Use
- Brand: Orbactiv IVGeneric: Orbactiv Oritavancin Injection
- Brand: FragminGeneric: Dalteparin
- Brand: PraxbindGeneric: Idarucizumab for Injection
- Brand: MulpletaGeneric: Lusutrombopag Tablets
- Brand: RiaSTAPGeneric: Fibrinogen Concentrate (Human) For Intravenous Use
- Brand: HeparinGeneric: Heparin
- Brand: Vitamin K1Generic: Aqueous Colloidal Solution of Vitamin K1
- Brand: HespanGeneric: 6% Hetastarch in 0 .9% Sodium Chloride Injection
- Brand: AlphanateGeneric: Antihemophilic Factor
- Brand: IplexGeneric: Mecasermin Rinfabate [rDNA origin] Injection
- Brand: Spinraza SolutionGeneric: Nusinersen
- Brand: ObizurGeneric: Antihemophilic Factor (Recombinant), Porcine Sequence] Powder for Intravenous Injection
- Brand: AndexxaGeneric: Coagulation Factor Xa (recombinant), Inactivated-zhzo for Injection
- Brand: TrettenGeneric: Catridecacog Coagulation Factor XIII A-Subunit (Recombinant)
- Brand: FeibaGeneric: Anti-inhibitor Coagulant Complex for Intravenous Use
- Brand: Feiba VHGeneric: Anti-Inhibitor Coagulant Complex, Vapor Heated
- Brand: UltravistGeneric: Iopromide Injection
- Brand: AptivusGeneric: Tipranavir
- Brand: BerinertGeneric: [C1 Esterase Inhibitor (Human)] Freeze-dried powder
- Brand: Heparin Sodium InjectionGeneric: Heparin Sodium Injection
- Brand: CelebrexGeneric: Celecoxib
- Brand: DepaconGeneric: Valproic Acid
- Brand: DepakeneGeneric: Valproic Acid
- Brand: Depakote Generic: Depakote Divalproex Sodium Tablets
- Brand: CorifactGeneric: Factor XIII Concentrate (Human) Lyophilized Powder Reconstitution for Intravenous Use
- Brand: Hemofil-MGeneric: [Antihemophilic Factor (Human), Method M, Monoclonal Purified] Nanofiltered
- Brand: Humate-PGeneric: Antihemophilic Factor/von Willebrand Factor Complex (Human) Injection
- Brand: ProtamineGeneric: Protamines
- Brand: Depakote ERGeneric: Divalproex Sodium
- Brand: Depakote Sprinkle CapsulesGeneric: Divalproex Sodium Sprinkle Capsules
- Brand: IprivaskGeneric: Desirudin for Injection
- Brand: MephytonGeneric: Phytonadione
- Brand: SolirisGeneric: Eculizumab
- Brand: HaegardaGeneric: C1 Esterase Inhibitor Subcutaneous [Human] Injection
- Brand: Lok PakGeneric: Heparin Lock Flush Solution
- Brand: XofigoGeneric: Radium Ra 223 Dichloride
- Brand: AquaMEPHYTONGeneric: Phytonadione Injection
- Brand: Cardiogen-82Generic: rubidium Rb 82 generator
- Brand: Indocin IVGeneric: Indomethacin Inj
- Brand: HepaGam BGeneric: Hepatitis B Immune Globulin (Human)
- Brand: VariZIGGeneric: Varicella Zoster Immune Globulin (Human) for Injection
- Brand: VoluvenGeneric: Hydroxyethyl Starch in Sodium Chloride Injection
- Brand: XiaflexGeneric: Collagenase Clostridium Histolyticum
- Brand: CeprotinGeneric: Protein C Concentrate
- Brand: Ruby-fill Generic: Rubidium Rb 82 Generator
- Brand: CyanocobalaminGeneric: Cyanocobalamin
- Brand: HEP-LOCK U/PGeneric: Preservative-Free Heparin Lock Flush Solution
- Brand: Hepflush 10Generic: Heparin Lock Flush Solution
- Brand: XareltoGeneric: Rivaroxaban Film-Coated Oral Tablets
- Brand: Thrombin-JMIGeneric: Thrombin Topical Bovine Origin
- Brand: KalbitorGeneric: Ecallantide Injection
- Brand: CimziaGeneric: Certolizumab Pegol Injection
- Brand: Calcium Chloride Injection 10%Generic: Calcium Chloride
- Brand: CyklokapronGeneric: Tranexamic Acid
- Brand: NascobalGeneric: Cyanocobalamin
- Brand: MutamycinGeneric: Mitomycin
- Brand: StavzorGeneric: Valproic Acid
Slideshows, Images, and Quizzes
- Hemophilia Quiz: Test Your IQ of This Blood DisorderSource: RxList
Learn about hemophilia causes, symptoms, treatments, life expectancy and lifestyles.
- Picture of Blood ClotSource: RxList
View an Illustration of Picture of Blood Clot and learn more about Medical Anatomy.
Diseases, Conditions, and Procedures
- Hemophilia A and B (Bleeding Disorders)Source: MedicineNet
What is hemophilia and what causes hemophilia? Learn the definitions of hemophilia A and hemophilia B, part of a group of genetic bleeding disorders. Discover the symptoms of hemophilia and the treatments available to hemophiliacs. See how hemophilia is inherited, and whether hemophilia is dominant or recessive.
- Rheumatoid Factor (RF)Source: MedicineNet
Rheumatoid factor (RF) is a blood test that helps to diagnose rheumatoid arthritis, lupus, and sarcoidosis. Elevated test results, or high levels, indicate severe disease. Learn about the normal range for rheumatoid factor.
- Rheumatoid Arthritis (RA)Source: MedicineNet
Rheumatoid arthritis (RA) is an autoimmune disease that causes chronic joint inflammation. Learn about stages, started ages, early signs, treatment options, types, causes, medications, diet, and exercise.
- Cancer Risk Factors and CausesSource: Government
Read about cancer risk factors and causes, such as age, family history, diet, alcohol and tobacco use, and exposure to sunlight, radiation, chemicals, viruses, and bacteria.
- Heart Disease in WomenSource: MedicineNet
Heart disease in women has somewhat different risk factors, symptoms, signs, and treatment compared to heart disease in men. Many women and health care professionals are unaware of the differences in heart disease between women and men. Heart disease in women can be prevented and reversed with lifestyle changes.
- Internal BleedingSource: MedicineNet
Internal bleeding is a serious consequence of trauma and can be life-threatening, requiring immediate medical attention. Learn about signs, causes, and treatment.
- Phlebitis (Thrombophlebitis)Source: MedicineNet
Phlebitis and thrombophlebitis are an inflammation of a vein, and blood clots that cause the inflammation. Signs and symptoms of phlebitis are pain, tenderness, redness, and a bulging vein are common symptoms. Causes of phlebitis and thrombophlebitis include sitting for prolonged periods and varicose veins. Treatment and recovery for phlebitis and thrombophlebitis depends on the cause. Complications of phlebitis and thrombophlebitis include DVT and pulmonary embolism.
- Head and Neck CancerSource: Government
Read about head and neck cancer diagnosis, symptoms (lump), treatments, research, support, types (adenocarcinoma, squamous cell carcinoma, metastatic squamous) and causes.
- Pernicious AnemiaSource: MedicineNet
Pernicious anemia is a type of blood disorder caused when the body does not make enough red blood cells due to lack of vitamin B12. Pernicious anemia causes a variety of symptoms and signs, for example, feelings of weakness, numbness, tingling, and personality changes. Treatment of pernicious anemia is an injection of vitamin B12 for life. Untreated pernicious anemia can be permanent and cause death.
- Meningococcemia (Meningococcal Disease) Source: MedicineNet
Meningococcal Disease is a severe bacterial infection with symptoms including fever, headache, fatigue, and body aches. Read about contagious, vaccines, prevention, treatment, causes, diagnosis, and prognosis information.
- Running (Jogging)Source: MedicineNet
Read about running tips, facts, history, techniques, health benefits, weight loss, injuries, shoes and clothing, training programs and schedules and famous runners.
- Pulmonary Embolism (Blood Clot in the Lung)Source: MedicineNet
Pulmonary embolism is a blood clot in the lung that causes signs and symptoms of chest pain, cough, and shortness of breath. Learn about PE causes, treatment options, diagnosis, death, and survival rate.
- Thrombocytopenia (Low Platelet Count)Source: MedicineNet
Learn about thrombocytopenia, a decreased number of platelets in the blood. There are many causes of thrombocytopenia such as decreased platelet production, increased platelet destruction or consumption, or increased splenic sequestration.
- Crohn's DiseaseSource: MedicineNet
Crohn's disease is an inflammatory bowel disease (IBD) that causes inflammation in the digestive tract. Crohn's disease symptoms and signs include abdominal pain, bloody diarrhea, and weight loss. There are a few types of Crohn's disease. Several Crohn's disease treatments exist, but there is no cure.
- Felty's SyndromeSource: MedicineNet
Felty's syndrome is a complication of rheumatoid arthritis. Read about the conditions of Felty's syndrome (rheumatoid arthritis, an enlarged spleen, an abnormally low white blood count), its symptoms, treatment, and complications.
- Biological TherapySource: MedicineNet
Biological therapy is a treatment that uses the body's immune system to treat a disease and protect the body from some of the side effects of certain treatments. Read about different types of biological therapy and their side effects.
- Types of Anxiety MedicationsSource: RxList
Common anxiety prescriptions are SSRIs, antidepressants, anti-anxiety medications, and beta-blockers. Learn how they work, types, side effects, drug interaction, and warnings.
- EMA Starts Another Review of Factor VIII-Containing ProductsSource: WebMD Health News
The European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has started a review of factor VIII-containing products to evaluate the risk of neutralizing antifactor VIII alloantibodies (inhibitors) developing in patients initiating treatment for hemophilia A, the agency announced today.
- FDA Approves Adynovate Factor for Hemophilia ASource: FDA
The U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A.
- FDA Approves First Factor X Concentrate for Rare Bleeding DisorderSource: FDA
The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency.
- FDA Clears Factor VIII Product Kovaltry for Hemophilia ASource: RxList
The US Food and Drug Administration (FDA) has approved Bayer AG's unmodified, full-length recombinant antihemophilic factor VIII product, Kovaltry, for the treatment of hemophilia A in children and adults, the company said.
- Many in U.S. Have at Least 1 Heart Risk FactorSource: WebMD Health News
About half of the U.S. population has at least one of three major risk factors for heart disease: high blood pressure, high cholesterol, or diabetes.
- Study: Age Not a Factor in Corneal TransplantSource: FDA
NIH-funded study finds that the age of a donor is not a factor in most corneal transplants.
- The X Factor: Why Women May Be Healthier Than MenSource: WebMD Health News
Is it all about the chromosomes? Find out why women may be healthier and live longer than men.
- Where You Live Is a Factor in HypertensionSource: WebMD Health News
A major risk for heart disease and stroke, race, place, and gender appear to be strongly associated with high blood pressure.
- FDA Approves Tretten to Treat Rare Genetic Clotting DisorderSource: FDA
The U.S. Food and Drug Administration approved Tretten, the first recombinant product for use in the routine prevention of bleeding in adults and children who have a rare clotting disorder, known as congenital Factor XIII A-subunit deficiency.
- For Five Cancers, Screening Skews Risk FactorsSource: WebMD Health News
Screening and diagnostic testing can affect the incidence of certain cancers and result in "self-fulfilling" risk factors associated with those cancers, according to a new essay by two major figures in the US cancer scene.
- FDA Approves Genetic Defect DrugSource: FDA
The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.
- FDA Approves Idelvion for Hemophilia BSource: WebMD Health News
The US Food and Drug Administration (FDA) today approved a drug for children and adults with hemophilia B called albutrepenonacog alfa (Idelvion, CSL Behring), which combines albumin with factor IX to reduce injection frequency.
- FDA Approves Eloctate for Patients with Hemophilia ASource: FDA
The U.S. Food and Drug Administration today approved Eloctate, Antihemophilic Factor (Recombinant), Fc fusion protein, for use in adults and children who have Hemophilia A.
- FDA Approves Rixubis for Preventing Bleeding EpisodesSource: FDA
The U.S. Food and Drug Administration yesterday approved Rixubis [Coagulation Factor IX (Recombinant)] for use in people with hemophilia B who are 16 years of age and older.
- FDA Approves Alprolix for Patients with Hemophilia BSource: FDA
The U.S. Food and Drug Administration today approved Alprolix, Coagulation Factor IX (Recombinant).
- FDA Approves Vonvendi to Treat Bleeding EpisodesSource: FDA
The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD).
- FDA Clears Rebinyn for Hemophilia BSource: WebMD Health News
- FDA Approves Afstyla for Adults, Children With Hemophilia ASource: RxList
The US Food and Drug Administration (FDA) has approved antihemophilic factor (recombinant), single chain (rVIII-single chain; Afstyla, CSL Behring) for on-demand treatment and control of bleeding episodes, routine prophylaxis to decrease the frequency of bleeding episodes, and perioperative management of bleeding in children and adults with hemophilia A (congenital factor VIII deficiency).
- Synthetic Cannabis Laced With Rat Poison a Risk to US Blood Supply, FDA WarnsSource: WebMD Health News
Illegal synthetic cannabis products laced with rat poison continue to be sold in the United States and pose a significant health risk not only to people who use these products but also the US blood supply, the US Food and Drug Administration (FDA) said this week in an update on the ongoing problem.
- FDA Approves Entyvio to Treat Ulcerative Colitis and Crohn's DiseaseSource: FDA
The U.S. Food and Drug Administration today approved Entyvio (vedolizumab) injection to treat adult patients with moderate to severe ulcerative colitis and adult patients with moderate to severe Crohn's disease.
- Psoriasis Linked to DiabetesSource: WebMD Health News
The chronic skin disorder psoriasis may raise the risk of diabetes, a large study shows.
- NSAIDs Plus Respiratory Infection Increase Heart Attack RiskSource: WebMD Health News
Nonsteroidal anti-inflammatory drug (NSAID) use during acute respiratory infection (ARI) increases the risk for acute myocardial infarction (AMI) 3.4-fold if taken by mouth and 7.2-fold with parenteral dosing compared with baseline risk without NSAID use or ARI, according to a report published online February 2 in the Journal of Infectious Diseases.
- Risk for Heart Attack, Stroke May Be UnderestimatedSource: WebMD Health News
A person's risk of heart disease is currently estimated in the short-term, meaning the likelihood of having heart disease in the next 10 years. This may be incorrect.
- FDA Approves New Treatment for HemophiliaSource: FDA
- Shingles Risk 70% Higher for Adults With AsthmaSource: FDA
- Stress Linked to StrokeSource: WebMD Health News
Need another reason to take life in stride and heed the advice, "Don't sweat the small stuff"?
- Coagulation, laser
- Laser coagulation
- Necrosis, coagulation
- X, factor
- Factor X
- Citrovorum factor
- Colony-stimulating factor
- CSF (colony-stimulating factor)
- E2F transcription factor 3
- Epidermal growth factor
- Epidermal growth factor receptor
- Factor V
- Factor V Leiden
- Factor VIII
- Factor, colony-stimulating
- Factor, rheumatoid
- Fibroblast growth factor receptor 2
- Granulocyte colony-stimulating factor
- Growth and differentiation factor 8
- Growth differentiation factor 8
- Monocyte chemotactic and activating factor
- Nerve growth factor
- Placental growth factor
- Rh factor
- Rheumatoid factor
- Risk factor
- Runt-related transcription factor 1
- Sun protection factor (SPF)
- Transcription factor
- Transforming growth factor
- Tumor necrosis factor
- Vascular endothelial growth factor (VEGF)
- Toxin, anthrax
- Hemostasis, genetics of
- Von Willebrand disease
- Gene, Y-linked
- Y-linked gene
- Vitamin K
- Annexin V
- Inheritance, holandric
- International normalized ratio
- Y-linked inheritance
- Prothrombin mutation G20210A
- Deficiency, vitamin K
- Maturity onset diabetes of the young
- Dysmetabolic syndrome X
- Hemophilia A
- Hemophilia B
- Progressive vaccinia
- Congenital neutropenia, severe (SCN)
- Disease, Kostmann
- Neutropenia, severe congenital (SCN)
- Syndrome, Kostmann
- Thrombocytopenia, heparin-induced
- Anti-angiogenesis drugs
- Endothelial progenitor cell
- Infection, middle ear
- Inheritance, multifactorial
- Normal growth rate
- Occupational disease
- Sex region Y
- Y sex-determining region